Microvascular dysfunction: causative role in the association between hypertension, insulin resistance and the metabolic syndrome?
- PMID: 17144887
- DOI: 10.1042/bse0420163
Microvascular dysfunction: causative role in the association between hypertension, insulin resistance and the metabolic syndrome?
Abstract
The metabolic syndrome defines a clustering of metabolic risk factors that confers an increased risk for type 2 diabetes and cardiovascular disease. The metabolic syndrome seems to have multiple etiological factors and microvascular dysfunction may be one potential factor explaining the clustering of multiple metabolic risk factors including hypertension, obesity, insulin resistance and glucose intolerance. Microvascular dysfunction may increase not only peripheral vascular resistance and blood pressure, but may also decrease insulin-mediated glucose uptake in muscle. The present article summarizes some of the data concerning the role of microvascular dysfunction in the metabolic syndrome.
Similar articles
-
Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension.Physiology (Bethesda). 2007 Aug;22:252-60. doi: 10.1152/physiol.00012.2007. Physiology (Bethesda). 2007. PMID: 17699878 Review.
-
The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.Semin Vasc Med. 2002 Feb;2(1):45-57. doi: 10.1055/s-2002-23095. Semin Vasc Med. 2002. PMID: 16222595 Review.
-
Vascular disease in the metabolic syndrome: do we need to target the microcirculation to treat large vessel disease?J Vasc Res. 2009;46(6):515-26. doi: 10.1159/000226220. Epub 2009 Jun 30. J Vasc Res. 2009. PMID: 19571572 Review.
-
Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome.Diabetes Obes Metab. 2006 Nov;8(6):603-10. doi: 10.1111/j.1463-1326.2005.00562.x. Diabetes Obes Metab. 2006. PMID: 17026484 Review.
-
Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance.Circulation. 2004 Jun 1;109(21):2529-35. doi: 10.1161/01.CIR.0000129772.26647.6F. Epub 2004 May 10. Circulation. 2004. PMID: 15136505
Cited by
-
Proteolytic receptor cleavage in the pathogenesis of blood rheology and co-morbidities in metabolic syndrome. Early forms of autodigestion.Biorheology. 2015;52(5-6):337-52. doi: 10.3233/BIR-15045. Biorheology. 2015. PMID: 26600265 Free PMC article. Review.
-
Obesity-Related Inflammation and Endothelial Dysfunction in COVID-19: Impact on Disease Severity.J Inflamm Res. 2021 May 27;14:2267-2276. doi: 10.2147/JIR.S282710. eCollection 2021. J Inflamm Res. 2021. PMID: 34079332 Free PMC article. Review.
-
Akt-mediated transactivation of the S1P1 receptor in caveolin-enriched microdomains regulates endothelial barrier enhancement by oxidized phospholipids.Circ Res. 2009 Apr 24;104(8):978-86. doi: 10.1161/CIRCRESAHA.108.193367. Epub 2009 Mar 12. Circ Res. 2009. PMID: 19286607 Free PMC article.
-
Role of Caveolae in the Development of Microvascular Dysfunction and Hyperglycemia in Type 2 Diabetes.Front Physiol. 2022 Feb 18;13:825018. doi: 10.3389/fphys.2022.825018. eCollection 2022. Front Physiol. 2022. PMID: 35250626 Free PMC article.
-
Milk-derived tripeptides IPP (Ile-Pro-Pro) and VPP (Val-Pro-Pro) promote adipocyte differentiation and inhibit inflammation in 3T3-F442A cells.PLoS One. 2015 Feb 25;10(2):e0117492. doi: 10.1371/journal.pone.0117492. eCollection 2015. PLoS One. 2015. PMID: 25714093 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical